top of page
Memory Treatment Centers, a leader in neurocognitive disease care, is excited to be one of the first to administer the groundbreaking Alzheimer's medication, Kisunla (Donanemab)
Through its national network of partners with Pure Infusion Suites, Memory Treatment Centers is offering FDA-approved therapy, Kisunla.
Jul 17, 20245 min read
bottom of page